Literature DB >> 7474893

Defective molybdopterin biosynthesis: clinical heterogeneity associated with molybdenum cofactor deficiency.

C Mize1, J L Johnson, K V Rajagopalan.   

Abstract

A patient with molybdenum cofactor deficiency (producing the biochemical abnormalities associated with deficiencies of sulphite oxidase and xanthine dehydrogenase) clinically expressed Marfan-like habitus with dislocated lenses, vertebral abnormality, learning disability, moderate hemiplegia, increased medial lentiform MRI signal and intermittent microscopic haematuria. S-Sulphocysteine was present in plasma and urine, and the oxidized derivative of a molybdopterin precursor (precursor Z), together with xanthine and hypoxanthine, were elevated in urine. Blood uric acid was < 1 mg/dl, while urinary urothione was not detected. These data indicate a functionally inadequate terminal enzyme for converting precursor Z to active molybdopterin (complementation group B of general molybdenum cofactor deficiency). Although the biochemical parameters were indicative of a severe deficiency state, the patient has survived into the third decade with a less severe clinical spectrum than has generally been associated with this disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7474893     DOI: 10.1007/bf00710416

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  8 in total

Review 1.  The pterin molybdenum cofactors.

Authors:  K V Rajagopalan; J L Johnson
Journal:  J Biol Chem       Date:  1992-05-25       Impact factor: 5.157

2.  Sulfite oxidase deficiency. Biochemical and clinical investigations of a hereditary metabolic disorder in sulfur metabolism.

Authors:  V E Shih; I F Abroms; J L Johnson; M Carney; R Mandell; R M Robb; J P Cloherty; K V Rajagopalan
Journal:  N Engl J Med       Date:  1977-11-10       Impact factor: 91.245

3.  The determination of oxalate in urine and urinary calculi by a new ion-chromatographic technique.

Authors:  W G Robertson; D S Scurr; A Smith; R L Orwell
Journal:  Clin Chim Acta       Date:  1982-11-24       Impact factor: 3.786

4.  Structural and metabolic relationship between the molybdenum cofactor and urothione.

Authors:  J L Johnson; K V Rajagopalan
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

5.  Separation and quantitation of oxypurines by isocratic high-pressure liquid chromatography: application to xanthinuria and the Lesch-Nyhan syndrome.

Authors:  J C Crawhall; K Itiaba; S Katz
Journal:  Biochem Med       Date:  1983-10

6.  Molybdenum cofactor deficiency in a patient previously characterized as deficient in sulfite oxidase.

Authors:  J L Johnson; M M Wuebbens; R Mandell; V E Shih
Journal:  Biochem Med Metab Biol       Date:  1988-08

7.  Molybdenum cofactor biosynthesis in humans. Identification of two complementation groups of cofactor-deficient patients and preliminary characterization of a diffusible molybdopterin precursor.

Authors:  J L Johnson; M M Wuebbens; R Mandell; V E Shih
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

8.  An HPLC assay for detection of elevated urinary S-sulphocysteine, a metabolic marker of sulphite oxidase deficiency.

Authors:  J L Johnson; K V Rajagopalan
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

  8 in total
  4 in total

1.  Synthesis, characterization, and spectroscopy of model molybdopterin complexes.

Authors:  Sharon J Nieter Burgmayer; Mary Kim; Rebecca Petit; Amy Rothkopf; Alison Kim; Shadia BelHamdounia; Ying Hou; Arpad Somogyi; Diana Habel-Rodriguez; Antonio Williams; Martin L Kirk
Journal:  J Inorg Biochem       Date:  2007-07-21       Impact factor: 4.155

2.  Arachnomelia syndrome in Simmental cattle is caused by a homozygous 2-bp deletion in the molybdenum cofactor synthesis step 1 gene (MOCS1).

Authors:  Johannes Buitkamp; Jördis Semmer; Kay-Uwe Götz
Journal:  BMC Genet       Date:  2011-01-21       Impact factor: 2.797

3.  Mild phenotype in Molybdenum cofactor deficiency: A new patient and review of the literature.

Authors:  Barbara Scelsa; Serena Gasperini; Andrea Righini; Maria Iascone; Valeria G Brazzoduro; Pierangelo Veggiotti
Journal:  Mol Genet Genomic Med       Date:  2019-03-21       Impact factor: 2.183

4.  The effect of dietary protein restriction in a case of molybdenum cofactor deficiency with MOCS1 mutation.

Authors:  Yu Abe; Yu Aihara; Wakaba Endo; Hiroshi Hasegawa; Kimiyoshi Ichida; Mitsugu Uematsu; Shigeo Kure
Journal:  Mol Genet Metab Rep       Date:  2021-02-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.